From: Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
Organs at risk (OARs)
Constraints
V50
V60
V65
V70
Rectal wall
n.a.
≤50%
≤20%
Bladder wall
Femoral heads
≤10%